# Fulton Financial Corp: financial statements, quarterly

FULT · Nasdaq · CIK 700564 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fult.md) · [Financials](/companies/fult/financials.md) · [Filings](/companies/fult/filings.md) · [Insiders](/companies/fult/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fult/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [56.0](/filings/0000700564-24-000053.md) | [60.1 d](/filings/0000700564-26-000006.md) | [57.1](/filings/0000700564-25-000020.md) | [113](/filings/0000700564-25-000048.md) | [59.7](/filings/0000700564-25-000057.md) | [65.9 d](/filings/0000700564-26-000006.md) | [67.2](/filings/0000700564-26-000016.md) | [69.1](/filings/0000700564-26-000033.md) | [70.4](/filings/0000700564-25-000057.md) | [70.0 d](/filings/0000700564-26-000006.md) | [69.8](/filings/0000700564-26-000016.md) | [79.3](/filings/0000700564-26-000033.md) |
| Interest expense | $m | [117](/filings/0000700564-23-000051.md) | [126 d](/filings/0000700564-24-000012.md) | [133](/filings/0000700564-24-000022.md) | [159](/filings/0000700564-24-000046.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [16.7](/filings/0000700564-24-000053.md) | [16.8 d](/filings/0000700564-26-000006.md) | [13.6](/filings/0000700564-25-000020.md) | [8.2](/filings/0000700564-25-000048.md) | [16.5](/filings/0000700564-25-000057.md) | [17.6 d](/filings/0000700564-26-000006.md) | [22.1](/filings/0000700564-26-000016.md) | [23.5](/filings/0000700564-26-000033.md) | [27.3](/filings/0000700564-25-000057.md) | [21.1 d](/filings/0000700564-26-000006.md) | [22.4](/filings/0000700564-26-000016.md) | [25.3](/filings/0000700564-26-000033.md) |
| Net income | $m | [72.1](/filings/0000700564-24-000053.md) | [64.3 d](/filings/0000700564-26-000006.md) | [61.9](/filings/0000700564-25-000020.md) | [95.0](/filings/0000700564-25-000048.md) | [63.2](/filings/0000700564-25-000057.md) | [68.6 d](/filings/0000700564-26-000006.md) | [93.0](/filings/0000700564-26-000016.md) | [99.2](/filings/0000700564-26-000033.md) | [100](/filings/0000700564-25-000057.md) | [99.0 d](/filings/0000700564-26-000006.md) | [94.8](/filings/0000700564-26-000016.md) | [102](/filings/0000700564-26-000033.md) |
| Diluted EPS | $ per share | [0.42](/filings/0000700564-24-000053.md) | not reported | [0.36](/filings/0000700564-25-000020.md) | [0.52](/filings/0000700564-25-000048.md) | [0.33](/filings/0000700564-25-000057.md) | not reported | [0.49](/filings/0000700564-26-000016.md) | [0.53](/filings/0000700564-26-000033.md) | [0.53](/filings/0000700564-25-000057.md) | not reported | [0.51](/filings/0000700564-26-000016.md) | [0.52](/filings/0000700564-26-000033.md) |
| Basic EPS | $ per share | [0.42](/filings/0000700564-24-000053.md) | not reported | [0.36](/filings/0000700564-25-000020.md) | [0.53](/filings/0000700564-25-000048.md) | [0.33](/filings/0000700564-25-000057.md) | not reported | [0.50](/filings/0000700564-26-000016.md) | [0.53](/filings/0000700564-26-000033.md) | [0.54](/filings/0000700564-25-000057.md) | not reported | [0.51](/filings/0000700564-26-000016.md) | [0.52](/filings/0000700564-26-000033.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [27.4](/filings/0000700564-23-000051.md) | [27.6](/filings/0000700564-25-000014.md) | [27.6](/filings/0000700564-24-000022.md) | [31.8](/filings/0000700564-24-000046.md) | [32.2](/filings/0000700564-24-000053.md) | [32.1](/filings/0000700564-26-000006.md) | [32.1](/filings/0000700564-25-000020.md) | [32.0](/filings/0000700564-25-000048.md) | [32.0](/filings/0000700564-25-000057.md) | [32.1](/filings/0000700564-26-000033.md) | [32.2](/filings/0000700564-26-000016.md) | [34.6](/filings/0000700564-26-000033.md) |
| Total liabilities | $bn | [24.8](/filings/0000700564-23-000051.md) | [24.8](/filings/0000700564-25-000014.md) | [24.9](/filings/0000700564-24-000022.md) | [28.7](/filings/0000700564-24-000046.md) | [29.0](/filings/0000700564-24-000053.md) | [28.9](/filings/0000700564-26-000006.md) | [28.9](/filings/0000700564-25-000020.md) | [28.7](/filings/0000700564-25-000048.md) | [28.6](/filings/0000700564-25-000057.md) | [28.6](/filings/0000700564-26-000033.md) | [28.7](/filings/0000700564-26-000016.md) | [30.7](/filings/0000700564-26-000033.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.6](/filings/0000700564-24-000053.md) | [2.8](/filings/0000700564-26-000006.md) | [2.8](/filings/0000700564-25-000048.md) | [3.1](/filings/0000700564-25-000057.md) | [3.2](/filings/0000700564-25-000057.md) | [3.2](/filings/0000700564-26-000033.md) | [3.3](/filings/0000700564-26-000033.md) | [3.3](/filings/0000700564-26-000033.md) | [3.4](/filings/0000700564-25-000057.md) | [3.5](/filings/0000700564-26-000033.md) | [3.5](/filings/0000700564-26-000033.md) | [3.8](/filings/0000700564-26-000033.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [203 d](/filings/0000700564-24-000053.md) | [(57.4) d](/filings/0000700564-26-000006.md) | [153](/filings/0000700564-25-000020.md) | [158 d](/filings/0000700564-25-000048.md) | [(22.0) d](/filings/0000700564-25-000057.md) | [128 d](/filings/0000700564-26-000006.md) | [0.7](/filings/0000700564-26-000016.md) | [91.7 d](/filings/0000700564-26-000033.md) | [116 d](/filings/0000700564-25-000057.md) | [96.0 d](/filings/0000700564-26-000006.md) | [115](/filings/0000700564-26-000016.md) | [99.7 d](/filings/0000700564-26-000033.md) |
| Dividends paid | $m | [30.3 d](/filings/0000700564-24-000053.md) | [30.4 d](/filings/0000700564-26-000006.md) | [28.7](/filings/0000700564-25-000020.md) | [35.2 d](/filings/0000700564-25-000048.md) | [32.2 d](/filings/0000700564-25-000057.md) | [35.6 d](/filings/0000700564-26-000006.md) | [35.4](/filings/0000700564-26-000016.md) | [35.4 d](/filings/0000700564-26-000033.md) | [35.3 d](/filings/0000700564-25-000057.md) | [35.1 d](/filings/0000700564-26-000006.md) | [36.7](/filings/0000700564-26-000016.md) | [38.9 d](/filings/0000700564-26-000033.md) |
| Share repurchases | $m | [30.5 d](/filings/0000700564-24-000053.md) | [6.1 d](/filings/0000700564-26-000006.md) | [30.3](/filings/0000700564-25-000020.md) | [0.0 d](/filings/0000700564-25-000048.md) | [0.0 d](/filings/0000700564-25-000057.md) | [0.0 d](/filings/0000700564-26-000006.md) | [0.6](/filings/0000700564-26-000016.md) | [14.5 d](/filings/0000700564-26-000033.md) | [31.0 d](/filings/0000700564-25-000057.md) | [19.9 d](/filings/0000700564-26-000006.md) | [24.6](/filings/0000700564-26-000016.md) | [18.3 d](/filings/0000700564-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q2 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [169](/filings/0000700564-23-000051.md) | [168](/filings/0000700564-24-000022.md) | [167](/filings/0000700564-24-000046.md) | [166](/filings/0000700564-24-000053.md) | [165](/filings/0000700564-25-000020.md) | [177](/filings/0000700564-25-000048.md) | [184](/filings/0000700564-25-000057.md) | [184](/filings/0000700564-26-000016.md) | [184](/filings/0000700564-26-000033.md) | [183](/filings/0000700564-25-000057.md) | [182](/filings/0000700564-26-000016.md) | [193](/filings/0000700564-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 190,914,563 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000700564-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.